TTD | Drug: D04CKG

Drug General Information
Drug ID	D04CKG
Former ID	DNCL003768
Drug Name	SPI-2012
Indication	Neutropenia; Breast cancer [ICD9: 174, 175; ICD10:C50]		Phase 3	[549072]
Company	SPECTRUM pharmaceuticals
Target and Pathway
Target(s)	Granulocyte colony-stimulating factor	Target Info	Modulator
KEGG Pathway	Cytokine-cytokine receptor interaction
	PI3K-Akt signaling pathway
	Jak-STAT signaling pathway
	Hematopoietic cell lineage
	Malaria
NetPath Pathway	IL1 Signaling Pathway
	TNFalpha Signaling Pathway
	TCR Signaling Pathway
WikiPathways	Cytokines and Inflammatory Response
WikiPathways	Hematopoietic Stem Cell Differentiation
References
Ref 549072	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031953)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information